-
HEOR Theater - Inclusive & Representative: How RWE Can Help to Fill Gaps Left by Clinical Trials
1:00PM-1:45PM EDT
-
HEOR Theater - Patients and Caregivers as Partners in Health Preference Research
11:00AM-11:45AM EDT
-
October 19: Metamodeling for Simulation-Based Optimization of Strategies in Healthcare- Virtual
-
Can the Benefits From Biosimilars be Sustainably Increased? Policy Recommendations for Europe, Middle East and Canada
-
October 12-13: Study Design with Real-World Data- Virtual
-
Health Insurance in Africa: Sustainability in Focus
-
Souring On SUCRAs: When Treatment Ranking Goes Wrong
-
Availability and Access to Innovative Therapies in Latin America
-
Fit for Local Context? Establishing or Improving Deliberative Processes for HTA
-
On the Validity of Statistical Analyses with Privacy-Preserving Synthetic Data
-
Signal - Episode 8
-
September 27-28: Pharmacoeconomic Modeling–Applications- Virtual
-
Network Meta-Analysis - Special Topics
-
Virtual ISPOR Asia Pacific Summit 2022
Virtual ISPOR Asia Pacific 2022, will offer a robust scientific program focused on in-depth studies of the current state of HEOR in the region, and how HEOR can support health systems confronting defining issues like healthcare quality, access and affordability in the Asia Pacific.
-
September 19-21: Budget Impact Analysis II: Applications and Design Issues- Virtual
-
Clinical Outcome Assessments in the Asia-Pacific Region: Strategy & Implementation
-
How Can Society Sustainably Benefit From Biosimilars? Global Learnings and Policy Recommendations for Australia
-
An Introduction to Network Meta-Analysis
-
Differentiating Between Patient Preferences, Patient Reported Outcomes and Patient Engagement
-
September 7: Budget Impact Analysis I: A 6-Step Approach- Virtual